Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase

被引：167
|
作者：
Degterev, A. [1 ]
Maki, J. L. [1 ]
Yuan, J. [2 ]
机构：
[1] Tufts Univ, Dept Biochem, Boston, MA 02111 USA
[2] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
来源：
CELL DEATH AND DIFFERENTIATION | 2013年 / 20卷 / 02期
关键词：
TARGET;
D O I：
10.1038/cdd.2012.133
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：366 / 366
页数：1
相关论文
共 50 条
  • [21] Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
    N Takahashi
    L Duprez
    S Grootjans
    A Cauwels
    W Nerinckx
    J B DuHadaway
    V Goossens
    R Roelandt
    F Van Hauwermeiren
    C Libert
    W Declercq
    N Callewaert
    G C Prendergast
    A Degterev
    J Yuan
    P Vandenabeele
    [J]. Cell Death & Disease, 2012, 3 : e437 - e437
  • [22] RIP1 Kinase Is an Oncogenic Driver in Melanoma
    Liu, Xiao Ying
    Lai, Fritz
    Yan, Xu Guang
    Jiang, Chen Chen
    Guo, Su Tang
    Wang, Chun Yan
    Croft, Amanda
    Tseng, Hsin-Yi
    Wilmott, James S.
    Scolyer, Richard A.
    Jin, Lei
    Zhang, Xu Dong
    [J]. CANCER RESEARCH, 2015, 75 (08) : 1736 - 1748
  • [23] Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase
    Holder, Sheldon
    Zemskova, Marina
    Zhang, Chao
    Tabrizizad, Maryam
    Bremer, Ryan
    Neidigh, Jonathan W.
    Lilly, Michael B.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) : 163 - 172
  • [24] Characterization of GSK'963: a structurally distinct, potent and selective inhibitor of RIP1 kinase
    Berger, S. B.
    Harris, P.
    Nagilla, R.
    Kasparcova, V
    Hoffman, S.
    Swift, B.
    Dare, L.
    Schaeffer, M.
    Capriotti, C.
    Ouellette, M.
    King, B. W.
    Wisnoski, D.
    Cox, J.
    Reilly, M.
    Marquis, R. W.
    Bertin, J.
    Gough, P. J.
    [J]. CELL DEATH DISCOVERY, 2015, 1
  • [25] Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase
    SB Berger
    P Harris
    R Nagilla
    V Kasparcova
    S Hoffman
    B Swift
    L Dare
    M Schaeffer
    C Capriotti
    M Ouellette
    BW King
    D Wisnoski
    J Cox
    M Reilly
    RW Marquis
    J Bertin
    PJ Gough
    [J]. Cell Death Discovery, 1
  • [26] Identification and Characterization of a Small-Molecule Inhibitor of Death-Associated Protein Kinase 1
    Wilbek, Theis S.
    Skovgaard, Tine
    Sorrell, Fiona J.
    Knapp, Stefan
    Berthelsen, Jens
    Stromgaard, Kristian
    [J]. CHEMBIOCHEM, 2015, 16 (01) : 59 - 63
  • [27] The kinase activity of Rip1 is not required for tumor necrosis factor-α-induced IκB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2
    Lee, TH
    Shank, J
    Cusson, N
    Kelliher, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) : 33185 - 33191
  • [28] A novel role for RIP1 kinase in mediating TNFα production
    Christofferson, D. E.
    Li, Y.
    Hitomi, J.
    Zhou, W.
    Upperman, C.
    Zhu, H.
    Gerber, S. A.
    Gygi, S.
    Yuan, J.
    [J]. CELL DEATH & DISEASE, 2012, 3 : e320 - e320
  • [29] Supramolecular alleviation of cardiotoxicity of a small-molecule kinase inhibitor
    Yang, Xue
    Huang, Qiaoxian
    Bardelang, David
    Wang, Chunming
    Lee, Simon M. Y.
    Wang, Ruibing
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2017, 15 (38) : 8046 - 8053
  • [30] Small-molecule kinase-inhibitor target assessment
    Kung, C
    Shokat, KM
    [J]. CHEMBIOCHEM, 2005, 6 (03) : 523 - 526
12345